TY - JOUR T1 - Is â–¼sibutramine more than a slim hope? JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 89 LP - 91 DO - 10.1136/dtb.2001.391289 VL - 39 IS - 12 A2 - , Y1 - 2001/12/01 UR - http://dtb.bmj.com/content/39/12/89.abstract N2 - Relevant BNF section: 4.5.2&#9660Sibutramine* (Reductil - Abbott Laboratories), an orally active monoamine re-uptake inhibitor, is marketed in the UK for treating overweight adults. The company claims that it "helps obese patients control their eating". Is the drug worth prescribing? ER -